2011
DOI: 10.1016/j.neulet.2011.05.058
|View full text |Cite
|
Sign up to set email alerts
|

Decreased expression of Bmal2 in patients with Parkinson's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
42
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 58 publications
(44 citation statements)
references
References 18 publications
1
42
0
1
Order By: Relevance
“…Clock, Npas2 and Bmal1 are the transcriptional activators of circadian clock system, which form a heterodimer to activate the feedback control genes Per and Cry (Buhr and Takahashi 2013; Partch et al 2014). In PD patients, sleep dysfunction seen in early Parkinson’s disease may reflect a more fundamental pathology in the molecular clock underlying circadian rhythms (Breen et al 2014; Verwey et al 2016), and decreased expression of Bmal1 (Cai et al 2010) and Bmal2 (Ding et al 2011) in leukocytes of PD patients was reported. Consistent with these observations, the expression of core clock genes Bmal1 and clock was decreased in a MPTP mouse model of PD (Hayashi et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Clock, Npas2 and Bmal1 are the transcriptional activators of circadian clock system, which form a heterodimer to activate the feedback control genes Per and Cry (Buhr and Takahashi 2013; Partch et al 2014). In PD patients, sleep dysfunction seen in early Parkinson’s disease may reflect a more fundamental pathology in the molecular clock underlying circadian rhythms (Breen et al 2014; Verwey et al 2016), and decreased expression of Bmal1 (Cai et al 2010) and Bmal2 (Ding et al 2011) in leukocytes of PD patients was reported. Consistent with these observations, the expression of core clock genes Bmal1 and clock was decreased in a MPTP mouse model of PD (Hayashi et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…They found decreased levels of BMAL1, but not PER1, and further described a correlation between PD severity and BMAL1 expression levels (24). Another study found that BMAL2 also had significantly lower levels of expression in patients with PD than controls, suggesting a dysregulation of molecular clock components in patients with PD (44). Thus, both of these diseases, and many neurodegenerative diseases in general, seem to have strong oxidative stress and circadian rhythm components.…”
Section: Neurodegenerative Diseasesmentioning
confidence: 97%
“…And the relative Bmal1 level had a correlation with motor severity and sleep quality [89]. In addition, this group continued to check other key circadian genes in PD, and the results showed that the expression pattern of Bmal2, but not Clock or Dec1, was altered compared to controls [90]. Recently, Cai and his coworkers also tested genetic polymorphisms in circadian disruptions and their susceptibility to PD pathogenesis.…”
Section: Clock Gene Differencementioning
confidence: 98%